Previous Article | Next Article ![]()
Journal of Virology, March 2006, p. 2309-2317, Vol. 80, No. 5
0022-538X/06/$08.00+0 doi:10.1128/JVI.80.5.2309-2317.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Robert L. Welschhans,1
Hariharan Jayaram,1,
Nigel D. Stow,2
Valerie G. Preston,2 and
Florante A. Quiocho1*
Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030,1 MRC Virology Unit, Institute of Virology, Glasgow G11 5JR, United Kingdom2
Received 25 October 2005/ Accepted 8 December 2005
|
|
|---|
|
|
|---|
2,000 Å in diameter) complex virus particle composed of an outer glycoprotein-containing envelope surrounding an amorphous protein layer or tegument. The tegument layer in turn surrounds an icosahedral capsid (1,250 Å in diameter) which encloses a linear double-stranded DNA (dsDNA) genome of
150 kb (50). Assembly of the herpesvirus virion is a complicated process that proceeds along an ordered morphogenetic pathway. Initially the capsid shell proteins "polymerize" in a scaffold-mediated fashion to form an intermediate particle or procapsid (35, 36). The procapsids are closed spherical structures that have a diameter similar to that of the mature capsid but are much more fragile, with open, elongated capsomeres that share very few connections between them (56). During maturation, the internal protein scaffold is cleaved by the viral protease and is displaced from inside the capsid as the DNA genome is packaged (10, 15, 28, 44). This process results in the conversion of the spherical procapsid into a more angularized form. Three types of angularized capsids have been identified: A capsids, which are empty with no scaffolding protein or DNA; B capsids, which contain scaffolding protein but no DNA; and C capsids, which contain the DNA genome but no scaffolding protein (16, 19, 43). C capsids represent the precursors of infectious particles, in contrast to the A and B capsids, which are dead-end products most likely arising from abortive DNA-packaging events and cleavage of the internal scaffold protein in the absence of DNA packaging, respectively.
Many aspects of capsid assembly and DNA packaging in the herpesviruses are similar to those in dsDNA bacteriophages such as
, T4, and P22 (7, 42). The replicated viral DNA genomes are synthesized as concatemers that are cleaved by the terminase complex at specific DNA sequences to generate unit-length genomes. DNA cleavage appears to be tightly coupled to insertion into the capsid, and in the absence of DNA packaging, no unit-length genomes are generated. Analysis of temperature-sensitive and null mutants of HSV-1 has demonstrated that six viral proteins (UL6, UL15, UL17, UL28, UL32, and UL33) are essential for initiation of the cleavage/packaging process (7). The terminase is likely to be a complex of UL15 with UL28 and possibly UL33 (2, 5, 12, 60), which actively pumps the DNA into the procapsid through a portal complex (comprised of 12 copies of UL6) located at a unique vertex (11, 37). The portal complex is an integral part of the capsid structure and harbors the binding sites for the terminase complex (58). The functions of UL17 and UL32 are not well defined, although both proteins have been implicated in targeting of capsids or capsid proteins to the sites of DNA packaging (25, 53).
A seventh gene product essential for HSV-1 DNA packaging, UL25, differs from the proteins described above in being required at a later stage of the DNA-packaging process. A null mutant of UL25 (KUL25NS) was isolated and has been characterized in two separate studies. McNab et al. (33) reported that A capsids and DNase I-sensitive unit-length genomes accumulated in the nuclei of cells infected with KUL25NS, suggesting that, although complete genomes could be packaged, the viral DNA was only transiently associated with the capsid and that UL25 was necessary for its retention. In contrast, Stow (51) reported that DNase-resistant (packaged) DNA was detectable in cells infected with the mutant virus and that although the amount of full-length DNA encapsidated was greatly reduced compared to that of wild-type virus, the mutant was impaired to a much lesser extent for molecules of up to about 100 kb in size. This suggested that UL25 might perform an important function during the final stages of the head-filling process. Despite these differences, the two reports agree that UL25 is essential at a stage subsequent to DNA cleavage and the initiation of DNA packaging. Such a role is consistent with the observation that procapsids contain little to no UL25, while B capsids contain some UL25 but much less than the DNA-containing C capsids (47, 55). It has been postulated that the UL25 protein acquired by the capsid during DNA packaging may function to seal the capsid after the viral DNA has been inserted (33) or to stabilize its structure as the DNA content increases towards that of a full-length genome (51). These hypotheses are also consistent with the observation that the association of other cleavage and packaging proteins with capsids is independent of UL25 (61).
There has been some work characterizing the binding partners of UL25 (38). In the absence of virus infection UL25 localized in the cytoplasm, but in the presence of the capsid triplex protein VP19C it was transported into the cell nuclei, suggesting that the two proteins interact. Direct interactions with the major capsid protein, VP5, from which the pentons and hexons are assembled, and the second triplex protein, VP23, were also detected. Immunogold labeling studies and capsid stripping experiments with guanidine-HCl suggested that UL25 was associated with the pentons and possibly also the hexons. C capsids are estimated to contain approximately 100 UL25 molecules (38). UL25 is retained in the mature virion, and its location on the outside of the C capsid suggests that it may possibly also play roles in capsid egress from the nucleus or interaction with components of the tegument layer (3, 38).
In order to advance our understanding of the structural basis of UL25 function, we have determined the crystallographic structure of an N-terminal deleted form (
1-133) of the 580-residue protein (UL25nt) to 2.1-Å resolution. The structure revealed a novel fold in which the unique flexible architecture appears well suited for participation in the dynamic processes of DNA encapsidation. UL25 and its homologues in other herpesviruses were additionally analyzed using the evolutionary trace (ET) (20, 27) to locate residues of likely functional importance on the surface of the molecule. This information should provide a useful starting point for future site-directed mutagenesis experiments.
|
|
|---|
Structure determination.
A two-wavelength data set from a crystal of selenomethione-substituted protein was collected on beamline 19ID at the SBC-CAT at the Advanced Photon Source (APS) at the Argonne National Laboratory. Data were processed with HKL2000 and merged with SCALEPACK (40). The crystals have one molecule in the asymmetric unit and belong to the orthogonal space group P212121 with unit-cell dimensions a = 52.6 Å, b = 67.6 Å, c = 119.6 Å, and
= ß =
= 90°. The positions of six of the nine selenomethionine sites in the molecule were determined using the direct methods program SnBv2.1 (17) with data collected at the selenomethionine peak wavelength. An additional two sites were found from residual maps calculated in SHARP (13). Multiwavelength anomalous dispersion (MAD) phases were calculated to 2.1-Å resolution using SHARP and the peak and inflection point wavelength data sets. The calculated electron density map was solvent flattened with DM (4) and used to build
85% of the total residues using O (23). The model was refined in CNS (8), interspersed with model building and fitting of water molecules. A total of 410 out of 446 residues (92%) were ordered within the asymmetric unit. Within the molecule, residues 249 to 254, 335 to 345, 417 to 425, 479 to 483, 511 to 513, and 578 to 580 were disordered. The current model, refined at 2.1-Å resolution, has an Rcryst of 22.7 and an Rfree of 25.1. The model has good geometry, with all but one of the backbone dihedral angles in the most favored or allowed regions.
Sequence alignment and evolutionary trace.
The multiple-sequence alignment for the full-length proteins encoded by the human herpesviruses was generated using the CLUSTALW (54) and BOXSHADE programs from the San Diego Supercomputer Center biology workbench at http://workbench.sdsc.edu/index.html. A multiple-sequence alignment for all the UL25nt domains from all known herpesvirus members was generated using CLUSTALW at http://www.ebi.ac.uk/clustalw/ and manually edited to remove residues corresponding to the unresolved portions of theUL25 structure. A probable frameshift error near the C terminus of the gallidherpesvirus 1 sequence was also corrected. This alignment was submitted totheEvolutionary Trace Server (TraceSuite II) (20) at http://www.cryst.bioc.cam.ac.uk/
jiye/evoltrace/evoltrace.html. Secondary-structure predictions were done usingPsiPred (22).
Illustrations. Electrostatic calculations were performed using GRASP. All ribbon diagrams and space-filling models were computed using PyMol (http://www.pymol.org) as a renderer.
Protein structure accession number. Coordinates have been deposited under PDB accession code 2F5U.
|
|
|---|
![]() View larger version (73K): [in a new window] |
FIG. 1. Sequence alignment of UL25 homologues from the eight human herpesviruses. The residues are colored green (completely conserved), yellow (identical residues), and cyan (similar residues). The secondary-structure elements are indicated above the sequence in red (helix), blue (strand), black (loop), and dotted line (disordered). The arrow indicates the position of the first ordered N-terminal residue (A134), and the helix and loop regions predicted for residues 1 to 133 are shown as gray wavy and straight lines, respectively.
|
-helices and a few minor ß-sheets (Fig. 2A). Emanating from the UL25 core are numerous loops, which in some cases stretch quite a distance from the core. Five such loops are quite flexible, as many of the residues that comprise them are disordered in the UL25nt crystals (Fig. 2A). |
View this table: [in a new window] |
TABLE 1. Crystallographic analysis statistics: data collection and phasing
|
|
View this table: [in a new window] |
TABLE 2. Crystallographic analysis statistics: refinement
|
![]() View larger version (76K): [in a new window] |
FIG. 2. The UL25nt structure. (A) Stereo view of the ribbon representation of the backbone structure. The secondary-structure elements are colored red ( -helices), blue (ß-strands), and green (loops). The dotted black lines (1 to 4) represent the disordered loops, labeled for orientation reference. N and C labels identify the amino- and carboxy-terminal ends, respectively. (B) Electrostatic surface representation of the electronegative face of UL25nt. (C) A 180° rotation of the view in panel B, showing the electropositive face of UL25nt.
|
The UL25 protein has a novel
plus ß protein-folding motif. A search for overall structural similarities against the DALI (18) database failed to reveal any significant matches. The lack of structural similarity to a known protein makes it difficult to infer structure/function relationships from the structure of UL25 alone. From the previous biochemical studies of this protein it has been suggested that UL25 binds to different partner proteins at particular steps within the capsid assembly and DNA-packaging process. The molecular architecture of UL25nt (a stable core of compact helices surrounded by long flexible loops) is consistent with the switching between conformational states as it interacts with its various protein partners during capsid assembly.
Evolutionary trace and sequence analysis. UL25 is one of the approximately 40 core genes conserved among all members of the alpha-, beta-, and gammaherpesvirus subfamilies (12). An initial alignment of the sequences of the homologous proteins encoded by the eight human herpesviruses, representing all three subfamilies, was made to locate regions of highest sequence conservation and likely functional importance.
Although the crystallographic structure does not include the N-terminal 133 residues of UL25, the secondary structure predicted for this region comprises a long alpha helix (residues 48 to 110), possibly involved in oligomerization via a coiled-coil interaction, preceded by a 45-residue unstructured N-terminal loop. The sequence alignment reveals this area, and in particular the N-terminal loop (residues 1 to 45), to be the least conserved portion of the protein (Fig. 1). Moreover, in the human cytomegalovirus (human herpesvirus 5 [HHV-5]) protein, the region between the predicted long alpha helix and the point corresponding to the first ordered amino acid (A134) in the UL25 structure is extended by approximately 50 amino acids. However, deletion mutants of UL25 lacking the N-terminal 45 residues complement the growth of the UL25 null mutant poorly, suggesting that this region is nevertheless important for protein function (V. Preston, unpublished results).
The greatest sequence similarity lies in the UL25nt portion of the protein. This region of the HSV-1 (HHV-1) protein was, as expected, most closely related to the corresponding proteins of the other human alphaherpesviruses, i.e., HSV-2 (HHV-2) and varicella-zoster virus (HHV-3), which exhibited similarities of 93% and 64%, respectively. The proteins encoded by the human beta- and gammaherpesviruses all exhibited sequence similarities to UL25nt in the range of 37 to 39%.
There are 24 residues within the UL25nt region which are completely conserved in the eight human herpesviruses. Mapping these amino acids onto the known structure of UL25nt revealed that they are mostly hydrophobic core residues located in the interior of the protein (Fig. 1 and 3). These residues are more likely to be critical in folding and maintaining the structural integrity of the protein than in playing a key functional role such as participating in protein-protein interactions.
![]() View larger version (35K): [in a new window] |
FIG. 3. Conserved residues of UL25nt. (A) Ribbon diagram of UL25nt, with the conserved residues in Fig. 1 in red. (B) A 180° rotation of the view in panel A.
|
The ET phylogenetic tree for UL25 is shown in Fig. 4, and the residues identified by the evolutionary trace analysis are shown in Fig. 5. The tree is in very close agreement with results of more detailed investigations of herpesvirus phylogeny based on larger protein sets and the use of alternative approaches for tree construction (30-32). The different partitions (P01 to P10) define the protein classes within the tree. Partitioning of the phylogenetic tree at the root (P01) (Fig. 4) results in a single class of proteins, and the conserved residues correlate with the most fundamental features of the protein. Twelve absolutely conserved residues are identified at this partition (Fig. 5), representing a subset of the residues conserved among the eight human herpesviruses (Fig. 1).
![]() View larger version (54K): [in a new window] |
FIG. 4. Evolutionary trace of herpesvirus UL25 homologues. P01 to P10 represent the different partitions of the ET phylogenetic tree. The branches defining the three herpesvirus subfamilies are labeled , ß, and . Key nodes discussed in the text are identified by A to D. Virus species names in boldface represent human viruses.
|
![]() View larger version (56K): [in a new window] |
FIG. 5. Evolutionary trace residues for partitions 01 to 10. The trace residues belonging to a given partition occur in the horizontal row corresponding to the partition. The conserved residues are outlined in a box, the class-specific residues are demarcated by an X, and the dashes reflect gaps in the alignment.
|
As a consequence of partitioning the phylogenetic tree, the ET analysis reveals conservation patterns that conventional sequence comparisons do not show. At P07, nine protein classes containing more than a single member are defined, which contribute to the positional information shown in Fig. 5. These classes, which are distributed among the three subfamilies, are exemplified by HSV-1, HSV-2, cercopithecine herpesvirus 1, and bovine herpesvirus 2 in the alphaherpesviruses; human, rhesus, and chimpanzee cytomegaloviruses in the betaherpesviruses; and Epstein-Barr virus (HHV-4) and cercopithecine HV-15 in the gammaherpesviruses. Mapping of the class-specific residues identified at this level to the surface of UL25nt revealed four clusters of particular interest (Fig. 5 and 6). The surface residues and the cluster to which each is classified are summarized in Table 3.
![]() View larger version (71K): [in a new window] |
FIG. 6. Evolutionary trace analysis. (A) The left and middle panels are a space-filling model and a ribbon trace, respectively, of UL25nt, with the class-specific exterior residues identified by the evolutionary trace shown in yellow. Cluster 1 is circled and identified with a 1. This cluster is also depicted in the electrostatic surface potential representation of the UL25nt structure (right). All three views are the same. (B, C, and D) Corresponding depictions of clusters 2, 3, and 4, respectively.
|
|
View this table: [in a new window] |
TABLE 3. Evolutionary trace residues within the identified four clusters
|
Models for UL25 function and biological implications. The HSV-1 UL25 protein has been proposed to be involved in the retention of packaged DNA within the capsid during the late stages of head filling (33, 51). There are phage proteins known which perform a function similar to that of UL25, as many aspects of the DNA-packaging mechanism of herpesviruses are analogous to those of dsDNA bacteriophages such as lambda, T4, and P22.
In many phages, following the packaging of the DNA, the portal is sealed to prevent the escape of the genome in a process known as head completion. Proteins that function to plug the portal during head completion include gp4, gp16, and gp26 of bacteriophage P22 and gp15 and gp16 of SPP1 (39, 41, 52). Mutants defective in any of these proteins exhibit a phenotype of unpackaged unit-length genomes similar to that described for the UL25 deletion mutant KUL25NS by McNab et al. (33), suggesting that UL25 may also be involved in the head completion process for HSV-1. The observations that HSV-1 C capsids contain more UL25 than B capsids and that only approximately half of the UL25 protein in B capsids is associated with pentons (38, 47, 55) are consistent with a role for UL25 in plugging the portal. However, no direct interaction with the UL6 portal protein has been reported, and it has not been determined whether UL25 is present at the unique portal vertex of capsids.
In the electron cryomicroscopy reconstructions of the entire capsid (62) the location of UL25 was not identified, suggesting that it does not conform to the icosahedral symmetry of the capsid and therefore its density is averaged out. However, as mentioned above, UL25 appears to associate with pentons (38), and such an interaction could be envisaged to have a role in either DNA retention or capsid stabilization. The penton channel is rather large, with a minimum diameter of
40 Å, and is electropositive in character (6), suggesting that escape of packaged DNA is more likely through one or more of the penton vertices than through the hexon channels, which are quite narrow (
20 Å in diameter) and are very electronegative. The dimensions of UL25 certainly allow for it or an oligomer to fit within the penton channel and act to potentially seal the DNA in the capsid.
The gpD protein of bacteriophage lambda and gpShp of bacteriophage 21 function as head stabilization proteins (57, 59). DNA packaging in bacteriophage lambda is accompanied by expansion of the prohead to an icosahedral shape and the binding of gpD. Interestingly, gpD is necessary for the packaging of full-length genomes, whereas gpD deletion mutants with genomes <82% of wild-type length are viable (49). This deficiency at the late stages of DNA packaging is similar to the phenotype of KUL25NS described by Stow (51), suggesting that rather than physically blocking the penton or portal channel, UL25 might act to stabilize the capsid against the increasing internal pressures generated during the packaging process. As is the case with lambda gpD, new UL25 binding sites might be revealed as the shape of the HSV-1 capsid is reconfigured during DNA entry. In addition to hexons and pentons, these sites could involve two other reported partners of UL25, the capsid triplex proteins VP19C and VP23 (38). Binding sites for the gpSoc and gpHoc proteins of bacteriophage T4 are similarly exposed on the phage head following the structural transitions associated with DNA packaging (26). Although neither protein is required for DNA encapsidation, gpSoc does have a role in stabilizing the capsid against extremes of pH and temperature (21, 46). Like UL25, lambda gpD is characterized by a surface of irregular secondary structure with the majority of residues in coils and loops (59).
A possible parallel to UL25 is seen in the outer scaffold protein D from FX174, in which a rigid core structure is surrounded by flexible regions that are capable of existing in different conformations depending on their local environment (14). It is possible that UL25 could act in a scaffold-like manner, but being added rather than removed from the capsid during the maturation process. This could facilitate subsequent stages of capsid maturation such as nuclear egress or acquisition of the tegument layer. Although the structures of phage proteins involved in DNA retention or head stabilization have been determined (39, 59) no significant similarity to UL25 in their folding pattern is apparent.
In addition to its role in DNA packaging, UL25 may also perform other important functions. It is likely that UL25 incorporated into C capsids establishes interactions that are important for capsid egress from the nucleus and the acquisition of the tegument layer by the virion. Studies on a UL25 ts mutant also indicate an essential early function for the virion-contained protein (1; V. Preston, unpublished results), and in this context it is interesting to note that UL25 has been implicated in the association of incoming capsids with microtubules (24). Although our structure does not include the N-terminal 133 amino acids, the predicted coiled coil (amino acids 49 to 110) is likely to contribute to oligomerization or other protein-protein interactions, and genetic studies on N-terminally truncated proteins confirm that residues in this region are important for virus replication (V. Preston, unpublished results). It remains to be determined whether DNA packaging and/or some other function is impaired in these truncated proteins.
Conclusion. We have presented the first crystallographic structure of a herpesvirus protein involved in DNA encapsidation. The structure revealed a novel fold with a unique "flexible" architecture, suggesting its adaptability in changing conformational states depending on its local environment. The electrostatic calculation reveals a distinct division of surface charges in which one face is highly electronegative, while the opposite face is electropositive. Evolutionary trace analysis incorporating UL25 homologues from the three herpesvirus subfamilies identified four clusters of residues that potentially form binding sites for other interacting proteins and mapped them to the structure. The distribution of binding sites, in combination with its "flexible" architecture and distinctive electrostatic pattern, suggests an inherent elasticity for UL25, which is a necessary characteristic of a protein involved in the dynamic processes of capsid assembly and DNA encapsidation. Although the structure determination cannot presently discriminate between possible models for UL25 function, it provides a basis for future studies on the role of this protein in DNA packaging and virion morphogenesis.
This research was supported in part by grants from the NIH (R01-AI38469) to Wah Chiu and the Welch Foundation (Q0581) to F.A.Q. Initial extensive work was funded by a grant from the Howard Hughes Medical Institute to F.A.Q.
Present address: Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138. ![]()
Present address: Howard Hughes Medical Institute and Department of Biochemistry, Brandeis University, Waltham, MA 02454. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»